Antimanic Agents - Pharmacology
Research News and Information

Saturday, November 21, 2009

An initial report of a new biological marker for bipolar disorder: P85 evoked brain potential.

30 Aug 2009 OBJECTIVES: Progress toward understanding the neurobiological and genetic underpinnings of bipolar disorder has been limited by the scarcity of potential biological markers that predict its occurrence. A measure of the integrity of brain inhibitory ... Read more...

Lithium treatment elongates primary cilia in the mouse brain and in cultured cells.

20 Aug 2009 The molecular mechanisms underlying the therapeutic effects of lithium, a first-line antimanic mood stabilizer, have not yet been fully elucidated. Treatment of the algae Chlamydomonas reinhardtii with lithium has been shown to induce elongation of ... Read more...

Treatment with lithium carbonate does not improve disease progression in two different strains of SOD1 mutant mice.

30 Jul 2009 It has been shown that chronic treatment with lithium carbonate (Li(2)CO(3)) in presymptomatic SOD1G93A transgenic male mice, a model of ALS, was able to remarkably increase their lifespan through the activation of autophagy and the promotion of ... Read more...

Latest indexed articles for 'Antimanic Agents - Pharmacology'

These are the very latest articles for this heading:

• An initial report of a new biological marker for bipolar disorder: P85 evoked brain potential. 30 Aug 2009
• Lithium treatment elongates primary cilia in the mouse brain and in cultured cells. 20 Aug 2009
• Treatment with lithium carbonate does not improve disease progression in two different strains of SOD1 mutant mice. 30 Jul 2009
• Lithium-induced enhancement of mitochondrial oxidative phosphorylation in human brain tissue. 30 Jul 2009
• GABA and cortical inhibition in motor and non-motor regions using combined TMS-EEG: a time analysis. 23 Jul 2009
• Calpains as a target for therapy of neurodegenerative diseases: putative role of lithium. 30 May 2009
• Lithium specificity in bipolar illness: a classic agent for the classic disorder. 30 May 2009
• Attenuation of amygdala atrophy with lamotrigine in patients receiving corticosteroid therapy. 30 May 2009
• Lithium and neuropsychiatric therapeutics: neuroplasticity via glycogen synthase kinase-3beta, beta-catenin, and neurotrophin cascades. 6 May 2009
• Mechanism of hypoxia-induced GCM1 degradation: implications for the pathogenesis of preeclampsia. 3 May 2009
• Valproate activates the Notch3/c-FLIP signaling cascade: a strategy to attenuate white matter hyperintensities in bipolar disorder in late life? 29 Apr 2009
• A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patients. 29 Apr 2009
• Differential expression of activating transcription factor-2 and c-Jun in the immature and adult rat hippocampus following lithium-pilocarpine induced status epilepticus. 28 Apr 2009
• Mood stabilizers increase prepulse inhibition in DBA/2NCrl mice. 27 Apr 2009
• The mood stabiliser lithium suppresses PIP3 signalling in Dictyostelium and human cells. 19 Apr 2009
• Glutamate-mediated calcium signaling: a potential target for lithium action. 7 Apr 2009
• Factors determining the effects of associative activation on habituation. 30 Mar 2009
• Overexpression of DeltaFosB is associated with attenuated cocaine-induced suppression of saccharin intake in mice. 30 Mar 2009
• A possible utilization of the mice forced swim test for modeling manic-like increase in vigor and goal-directed behavior. 29 Mar 2009
• Prolyl oligopeptidase binds to GAP-43 and functions without its peptidase activity. 26 Mar 2009

See a longer list of these articles.

Technical information about 'Antimanic Agents'

Definition: Agents that are used to treat bipolar disorders or mania associated with other affective disorders.

Registry Number: 0

Descriptor UI: D018692

Alternative terms: Antimanic Agents; Agents, Antimanic; Antimanic Drugs; Drugs, Antimanic; Antimanics;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D27.505.696.277.950.025; D27.505.954.427.210.950.025; D27.505.954.427.700.872.025;

History Note: 95

Technical Notes: tranquilizing agents; consider also BIPOLAR DISORDER /drug ther